Fibrobiologics Inc. Insider Trading
FBLG
Insiders bought 120K on the open market and sold nothing.
Get an email when FBLG's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Mar 4 | Hamid Khoja Chief Scientific Officer | Bought | 30,000 | $0.38 | 11K | 96% | Form 4 |
| Mar 2 – 4 | Pete O'Heeron Chief Executive Officer | Bought 3 parts | 51,500 | $0.38 average | 20K | 0.9% | Form 4 |
| Mar 2 | Jason Davis Chief Financial Officer | Bought | 70,000 | $0.41 | 29K | New | Form 4 |
| Feb 27 | Ruben A Garcia General Counsel | Bought | 40,000 | $0.33 | 13K | 29% | Form 4 |
| Dec 11, 2025 | Ruben A Garcia General Counsel | Bought | 140,000 | $0.34 | 48K | New | Form 4 |
| May 27, 2025 | Hamid Khoja Chief Scientific Officer | Bought | 20,000 | $0.84 | 17K | 178% | Form 4 |
- Mar 4Hamid KhojaChief Scientific Officer · bought 30,000 at $0.3811K96% of stake
- Mar 2 – 4Pete O'HeeronChief Executive Officer · bought 51,500 at avg $0.3820K0.9% of stake
- Mar 2Jason DavisChief Financial Officer · bought 70,000 at $0.4129KNew position
- Feb 27Ruben A GarciaGeneral Counsel · bought 40,000 at $0.3313K29% of stake
- Dec 11, 2025Ruben A GarciaGeneral Counsel · bought 140,000 at $0.3448KNew position
- May 27, 2025Hamid KhojaChief Scientific Officer · bought 20,000 at $0.8417K178% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Pharmaceutical Preparations · Pick stocks to compare with FBLG
Spot a number that looks wrong? Check it in FBLG's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing FBLG
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.